YHB Investment Advisors Inc. Reduces Position in CVS Health Corporation (NYSE:CVS)

YHB Investment Advisors Inc. trimmed its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 43.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 6,960 shares of the pharmacy operator's stock after selling 5,385 shares during the quarter. YHB Investment Advisors Inc.'s holdings in CVS Health were worth $472,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of CVS. Whitebox Advisors LLC purchased a new position in CVS Health in the fourth quarter worth $249,000. Fairfax Financial Holdings Ltd. Can bought a new position in shares of CVS Health during the 4th quarter valued at about $121,742,000. Lazard Asset Management LLC raised its holdings in shares of CVS Health by 7.3% during the 4th quarter. Lazard Asset Management LLC now owns 4,290,953 shares of the pharmacy operator's stock valued at $192,617,000 after buying an additional 293,406 shares in the last quarter. Seizert Capital Partners LLC boosted its stake in CVS Health by 22.8% in the fourth quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator's stock worth $25,566,000 after buying an additional 105,708 shares in the last quarter. Finally, Capital World Investors raised its stake in shares of CVS Health by 26.6% during the fourth quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock worth $2,739,927,000 after acquiring an additional 12,819,148 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on CVS shares. Cowen reiterated a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Barclays set a $79.00 target price on CVS Health and gave the company an "overweight" rating in a report on Monday, June 2nd. Morgan Stanley reaffirmed an "overweight" rating on shares of CVS Health in a research note on Tuesday, April 15th. Robert W. Baird raised their target price on shares of CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a report on Tuesday, April 15th. Finally, Truist Financial upped their price target on shares of CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a report on Monday, May 12th. Two analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, CVS Health currently has an average rating of "Moderate Buy" and an average price target of $74.75.

Insider Buying and Selling

In other news, Director Guy P. Sansone bought 1,570 shares of the firm's stock in a transaction on Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the completion of the acquisition, the director now owns 12,007 shares of the company's stock, valued at approximately $764,845.90. This represents a 15.04% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.22% of the stock is currently owned by company insiders.

CVS Health Stock Up 2.4%

Shares of CVS stock traded up $1.59 during mid-day trading on Thursday, reaching $67.96. 1,060,465 shares of the company's stock traded hands, compared to its average volume of 10,872,110. The company's 50-day moving average price is $64.81 and its 200-day moving average price is $60.62. The company has a market cap of $85.97 billion, a P/E ratio of 16.24, a P/E/G ratio of 0.97 and a beta of 0.56. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter last year, the firm earned $1.31 earnings per share. The business's revenue for the quarter was up 7.0% on a year-over-year basis. On average, equities analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.